Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

BMS expands collaboration with Nektar, sending shares soaring

BMS expands collaboration with Nektar, sending shares soaring Keytruda has mainly established its dominance thanks to its efficacy in NSCLC, an indication that Opdivo has found hard to crack. ... In addition to the Nektar collaboration and research, BMS has been testing Opdivo with its own CTLA4 blocker Yervoy

Keytruda claims first place in bladder cancer race

Keytruda claims first place in bladder cancer race Keytruda gets the new indication ahead of rivals in the checkpoint inhibitor class, including Bristol-Myers Squibb’s Opdivo (nivolumab), Roche’s Tecentriq (atezolizumab) and AstraZeneca’s Imfinzi (durvalumab) that are

Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer

Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer Merck’s Keytruda (pembrolizumab), Bristol-Myers Squibb’s Opdivo (nivolumab), Roche’s Tecentriq (atezolizumab) and AstraZeneca’s Imfinzi (durvalumab) are all approved for use in bladder cancer, albeit in differing settings.

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus GSK can't catch up with immunotherapy leaders, such as Merck &Co’s Keytruda and Bristol-Myers Squibb’s Opdivo, but its R&D chief Hal Barron (pictured right) has still

FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis

FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis year – it’s second biggest product after cancer immunotherapy Opdivo (nivolumab) – and added $3.4bn to Pfizer’s top line.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...
The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....

Infographics